謝 宗翰

Medicine & Life Sciences

1. MPT0L145 100%
2. Neoplasms 83%
3. Atypical Teratoid Tumor 58%
4. Pediatrics 53%
5. 5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzimidazol-5-yl)pyrimidin-2-yl)amine 49%
6. Hypertensive Nephropathy 45%
7. Sarcoma 41%
8. Gene Rearrangement 41%
9. Ependymoma 35%
10. MicroRNAs 35%
11. Autophagy 33%
12. Podocytes 33%
13. Urinary Bladder Neoplasms 30%
14. Genes 30%
15. Medulloblastoma 27%
16. Taiwan 26%
17. Phosphatidylinositol 3-Kinases 26%
18. Therapeutics 26%
19. Up-Regulation 26%
20. poly ICLC 25%
21. Cell Proliferation 24%
22. Fluorescence In Situ Hybridization 24%
23. Down-Regulation 23%
24. Organic Cation Transporter 2 23%
25. Foot 22%
26. Myoepithelioma 22%
27. Genome 22%
28. Argininosuccinate Synthase 22%
29. Brain Neoplasms 20%
30. Rhabdoid Tumor 20%
31. Hepatocellular Carcinoma 20%
32. Endothelial Cells 20%
33. Dermatofibrosarcoma 19%
34. Proto-Oncogene Proteins c-sis 19%
35. Interleukin-11 19%
36. Gene Fusion 19%
37. Matrix Metalloproteinase 13 18%
38. Sex Differentiation 17%
39. Growth Inhibitors 17%
40. Clustered Regularly Interspaced Short Palindromic Repeats 17%
41. Natriuretic Peptides 16%
42. Central Nervous System Neoplasms 16%
43. DNA Methylation 16%
44. Bortezomib 16%
45. Brown Adipose Tissue 16%
46. Bone Morphogenetic Proteins 16%